Company Monitoring Page for Eli-Lilly

latest headlines for company on cafepharma

GLP-1 global obesity market to reach $111B by 2033, despite headwinds: GlobalData
BioSpace
Fri, 06/14/24 - 11:46 am
Tags:
GLP-1 agonists, Novo Nordisk, Eli Lilly, obesity, weight loss
Employer coverage for weight-loss drugs rises sharply, survey finds
Reuters
Thu, 06/13/24 - 11:05 pm
Tags:
insurance, weight loss, obesity, Eli Lilly, Novo Nordisk, Wegovy, Zepbound
Lilly’s adcomm win shows amyloid and tau will likely dominate Alzheimer’s — for now
Pharma Voice
Thu, 06/13/24 - 10:50 am
Tags:
Eli Lilly, Alzheimer's disease, donanemab, amyloid, tau
Lilly Alzheimer’s drug gets unanimous backing of FDA panel
BioPharma Dive
Mon, 06/10/24 - 06:09 pm
Tags:
Eli Lilly, FDA, donanemab, Alzheimer's disease
Eli Lilly exec says seeing out of pocket payments for obesity drug in US
Reuters
Mon, 06/10/24 - 06:06 pm
Tags:
Eli Lilly, Zepbound, Mounjaro, patients, obesity, diabetes
Added health benefits of Wegovy, Zepbound could attract more men, doctors say
Reuters
Mon, 06/10/24 - 11:15 am
Tags:
Novo Nordisk, Wegovy, Eli Lilly, Zepbound, men's health, sleep apnea, heart disease
Boehringer, Lilly face off in MASH at EASL
Pharmaphorum
Mon, 06/10/24 - 11:14 am
Tags:
Eli Lilly, Boehringer Ingelheim, MASH, EASL, tirzepatide, survodutide
FDA staff raise no major concerns about Eli Lilly Alzheimer's drug
Reuters
Thu, 06/6/24 - 09:11 pm
Tags:
Eli Lilly, FDA, Alzheimer's disease, donanemab
FDA lays out donanemab concerns ahead of meeting, as Lilly vigorously defends safety
Fierce Biotech
Thu, 06/6/24 - 11:45 am
Tags:
Eli Lilly, donanemab, FDA, Alzheimer's disease
Top ten biopharma R&D deals of 2024
Nature
Wed, 06/5/24 - 11:24 am
Tags:
R&D, Novartis, Argo Biopharmaceutical, Roche, MOMA Therapeutics, Boehringer Ingelheim, Suzhou Ribo Life Science, Eli Lilly, Isomorphic Labs, Merus, Gilead Sciences, Novo Nordisk, Neomorph, AbbVie, Umoja Biopharma, Merck KGaA, Caris Life Sciences, Voyager Therapeutics
Lilly’s Tirzepatide Shows Positive Phase II NASH Data, Tees Up Potential Expansion
BioSpace
Wed, 06/5/24 - 11:08 am
Tags:
Eli Lilly, NASH, MASH, clinical trials, tirzepatide
Lilly wins NICE endorsement for tirzepatide in obesity—with a catch
Fierce Pharma
Tue, 06/4/24 - 11:38 am
Tags:
Eli Lilly, UK, NICE, tirzepatide, obesity, type 2 diabetes, diabetes
Eli Lilly adds ALS drug prospect with QurAlis deal
BioPharma Dive
Mon, 06/3/24 - 11:55 am
Tags:
Eli Lilly, ALS, QurAlis, RNA
'We're going to miss the next Keytruda': Lilly, Merck, Gilead and PhRMA CEOs talk IRA consequences
Fierce Pharma
Mon, 06/3/24 - 11:54 am
Tags:
Merck, Eli Lilly, Gilead Sciences, innovation, Inflation Reduction Act, Keytruda, PhRMA
Weight loss drugs are so hard to find that this company built a tracker
Axios
Thu, 05/30/24 - 11:09 pm
Tags:
Novo Nordisk, Eli Lilly, Wegovy, Zepbound, weight loss, obesity, drug shortages, Ro
FDA Approves Selpercatinib for Pediatric Patients With RET-Altered Metastatic Thyroid Cancer, Solid Tumors
Oncology Nursing News
Wed, 05/29/24 - 09:41 pm
Tags:
Eli Lilly, FDA, Retevmo, pediatrics, thyroid cancer
Weight-loss drug forecasts jump to $150 billion as supply grows
Reuters
Wed, 05/29/24 - 11:48 am
Tags:
Eli Lilly, Novo Nordisk, weight loss, Wegovy, Mounjaro
Lilly invests further $5.3 bln in new Indiana site as obesity drug demand soars
Reuters
Fri, 05/24/24 - 11:12 am
Tags:
Eli Lilly, obesity, Indiana, drug manufacturing
Pfizer and Lilly are elbowing into the direct-to-consumer market. Will it work?
BioPharma Dive
Wed, 05/22/24 - 10:28 pm
Tags:
Eli Lilly, Pfizer, DTC
Eli Lilly’s mirikizumab shows promise in Phase III Crohn’s disease trial
Clinical Trials Arena
Wed, 05/22/24 - 11:17 am
Tags:
Eli Lilly, clinical trials, Crohn's disase, mirikizumab

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.